Carl A. Baxter

1.9k total citations
55 papers, 1.4k citations indexed

About

Carl A. Baxter is a scholar working on Organic Chemistry, Surgery and Economics and Econometrics. According to data from OpenAlex, Carl A. Baxter has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 12 papers in Surgery and 11 papers in Economics and Econometrics. Recurrent topics in Carl A. Baxter's work include Lipoproteins and Cardiovascular Health (12 papers), Catalytic C–H Functionalization Methods (9 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Carl A. Baxter is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Catalytic C–H Functionalization Methods (9 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Carl A. Baxter collaborates with scholars based in United Kingdom, United States and Germany. Carl A. Baxter's co-authors include Amir H. Hoveyda, M. Kevin Brown, Tricia L. May, Ed Cleator, Debra J. Wallace, Gavin W. Stewart, Robert A. Reamer, Karel M. J. Brands, Neil A. Strotman and Baishali Ambegaonkar and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Carl A. Baxter

51 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl A. Baxter United Kingdom 21 834 250 237 236 153 55 1.4k
David Hageman Netherlands 15 431 0.5× 67 0.3× 250 1.1× 273 1.2× 47 0.3× 29 953
Christoph Hirschhäuser Germany 15 254 0.3× 40 0.2× 146 0.6× 185 0.8× 93 0.6× 30 794
Rumiko Shimazawa Japan 20 382 0.5× 56 0.2× 26 0.1× 261 1.1× 37 0.2× 50 864
Pankaj Patel India 20 393 0.5× 22 0.1× 196 0.8× 535 2.3× 302 2.0× 108 1.7k
Xin‐Feng Wang China 20 279 0.3× 134 0.5× 101 0.4× 337 1.4× 26 0.2× 82 1.3k
Thomas Antonsson Sweden 12 257 0.3× 63 0.3× 125 0.5× 176 0.7× 13 0.1× 25 842
Yuji Nakano Australia 19 589 0.7× 114 0.5× 26 0.1× 185 0.8× 13 0.1× 55 966
N. Sanz Spain 20 77 0.1× 290 1.2× 71 0.3× 156 0.7× 30 0.2× 51 998
Jordi Soler Soler Spain 17 211 0.3× 141 0.6× 131 0.6× 218 0.9× 14 0.1× 58 1.0k
Zhiying Huang China 11 112 0.1× 88 0.4× 73 0.3× 68 0.3× 33 0.2× 26 482

Countries citing papers authored by Carl A. Baxter

Since Specialization
Citations

This map shows the geographic impact of Carl A. Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl A. Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl A. Baxter more than expected).

Fields of papers citing papers by Carl A. Baxter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl A. Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl A. Baxter. The network helps show where Carl A. Baxter may publish in the future.

Co-authorship network of co-authors of Carl A. Baxter

This figure shows the co-authorship network connecting the top 25 collaborators of Carl A. Baxter. A scholar is included among the top collaborators of Carl A. Baxter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl A. Baxter. Carl A. Baxter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Adams, Fred C., Carl A. Baxter, Graham A. MacGregor, et al.. (2024). EPS10.08 LONGITUDE: an observational study of the long-term effectiveness of ELX/TEZ/IVA in people with CF using data from the UK CF Registry — preliminary results from the subgroup aged 6–11 years. Journal of Cystic Fibrosis. 23. S65–S65. 1 indexed citations
4.
Benčina, Goran, et al.. (2023). Indirect Costs Due to Lung Cancer-Related Premature Mortality in Four European Countries. Advances in Therapy. 40(7). 3056–3069. 10 indexed citations
5.
Hofmarcher, Thomas, et al.. (2023). Access to novel cancer medicines in four countries in Central and Eastern Europe in relation to clinical benefit. ESMO Open. 8(4). 101593–101593. 9 indexed citations
6.
Berg, Jan Willem van den, et al.. (2022). The demographics, clinical characteristics and quality of life of patients with chronic cough from the Isala Cough Clinic in the Netherlands. ERJ Open Research. 8(4). 232–2022. 10 indexed citations
7.
Baxter, Carl A., Sylvia Hartl, Stina Salomonsson, et al.. (2021). Distribution of chronic cough phenotypes in the general population: A cross-sectional analysis of the LEAD cohort in Austria. Respiratory Medicine. 192. 106726–106726. 20 indexed citations
8.
Ferrières, Jean, Dominik Lautsch, Peter Bramlage, et al.. (2020). Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndrome. Archives of cardiovascular diseases. 113(10). 617–629. 4 indexed citations
9.
10.
Nevskaya, Tatiana, Boyang Zheng, Carl A. Baxter, et al.. (2019). Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis. Lara D. Veeken. 59(7). 1715–1724. 15 indexed citations
11.
Ferrières, Jean, Dominik Lautsch, Baishali Ambegaonkar, et al.. (2018). Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study. International Journal of Cardiology. 270. 21–27. 9 indexed citations
12.
Alkhenizan, Abdullah, Martin Horack, Philippe Brudi, et al.. (2018). Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia. Saudi Medical Journal. 39(7). 697–704. 3 indexed citations
13.
Lorenzi, Maria, Baishali Ambegaonkar, Carl A. Baxter, et al.. (2018). Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy. Clinical Research in Cardiology. 108(5). 487–509. 21 indexed citations
14.
Gitt, Anselm K., Dominik Lautsch, Jean Ferrières, et al.. (2018). Contemporary data on treatment practices for low-density lipoprotein cholesterol in 6794 patients with stable coronary heart disease across the world. Data in Brief. 18. 1937–1940. 7 indexed citations
15.
Gitt, Anselm K., Dominik Lautsch, Jean Ferrières, et al.. (2017). Contemporary data on treatment practices for low-density lipoprotein cholesterol in 3867 patients who had suffered an acute coronary syndrome across the world. Data in Brief. 16. 369–375. 5 indexed citations
16.
Gitt, Anselm K., Dominik Lautsch, Jean Ferrières, et al.. (2017). Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II. Atherosclerosis. 266. 158–166. 88 indexed citations
17.
Bain, Steve, Eric Druyts, Chakrapani Balijepalli, et al.. (2016). Cardiovascular events and all‐cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A B ayesian meta‐analysis of survival data. Diabetes Obesity and Metabolism. 19(3). 329–335. 86 indexed citations
18.
Maddess, Matthew L., Jeremy P. Scott, Carl A. Baxter, et al.. (2014). Enantioselective Synthesis of a Highly Substituted Tetrahydrofluorene Derivative as a Potent and Selective Estrogen Receptor Beta Agonist. Organic Process Research & Development. 18(4). 528–538. 11 indexed citations
19.
Brown, M. Kevin, Tricia L. May, Carl A. Baxter, & Amir H. Hoveyda. (2007). All‐Carbon Quaternary Stereogenic Centers by Enantioselective Cu‐Catalyzed Conjugate Additions Promoted by a Chiral N‐Heterocyclic Carbene. Angewandte Chemie International Edition. 46(7). 1097–1100. 199 indexed citations
20.
Clark, J. Stephen, Carl A. Baxter, & José L. Castro. (2005). Synthesis of the Tricyclic Core of the Marine Natural Product Labiatin A. Synthesis. 3398–3404. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Hageman Breakdown of academic impact, for papers by Christoph Hirschhäuser Breakdown of academic impact, for papers by Rumiko Shimazawa Breakdown of academic impact, for papers by Pankaj Patel Breakdown of academic impact, for papers by Xin‐Feng Wang Breakdown of academic impact, for papers by Thomas Antonsson Breakdown of academic impact, for papers by Yuji Nakano Breakdown of academic impact, for papers by N. Sanz Breakdown of academic impact, for papers by Jordi Soler Soler Breakdown of academic impact, for papers by Zhiying Huang
Rankless by CCL
2026